Related Experiment Video
Updated: May 13, 2026

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration
Published on: May 19, 2016
MRP1 but not MDR1 is associated with response to neoadjuvant chemotherapy in breast cancer patients
Mohsen Taheri1, Frouzandeh Mahjoubi
1Division of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.
Abstract:
A major problem in the treatment of breast cancer is the development of resistance to chemotherapeutic agents. Although the role of multidrug resistance 1 (MDR1) and multidrug resistance associated protein 1 (MRP1) in inducing drug resistance in many cancers has been widely investigated the clinical significance of expression of these genes in breast cancer remains unclear and the data is still controversial. We investigated the expression of MDR1 and MRP1 in breast cancer patients as well as the possible correlation between MDR1 and MRP1 and clinical response to chemotherapy. In the present study, MDR1 and MRP1 gene expression were investigated by real time reverse transcription polymerase chain reaction (RT-PCR) assay in 54 breast cancer tumors and in corresponding adjacent normal tissues before neoadjuvant chemotherapy. The expression level of MDR1 and MRP1 were significantly higher in breast tumors than normal breast tissues. Although a significant relationship was found between the MRP1 expression and response to treatment no association was observed between MDR1 expression and response to treatment. MDR1 and MRP1 expression levels have been shown to be independent of tumor size, histological grade and the status of progesterone or estrogen receptor.
Insights
Multidrug resistance 1 (MDR1) and multidrug resistance associated protein 1 (MRP1) are elevated in breast tumors. Only MRP1 expression correlated with chemotherapy response, suggesting its clinical significance in breast cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Chemotherapeutic resistance is a major challenge in breast cancer treatment.
- The roles of multidrug resistance 1 (MDR1) and multidrug resistance associated protein 1 (MRP1) in drug resistance are established in many cancers, but their clinical significance in breast cancer is debated.
- Understanding MDR1 and MRP1 expression is crucial for predicting treatment outcomes.
Purpose of the Study:
- To investigate the expression levels of MDR1 and MRP1 in breast cancer tissues compared to normal tissues.
- To determine the correlation between MDR1 and MRP1 expression and clinical response to neoadjuvant chemotherapy in breast cancer patients.
- To assess the relationship between MDR1/MRP1 expression and clinicopathological features.
Main Methods:
- Gene expression analysis using real-time reverse transcription polymerase chain reaction (RT-PCR).
- Study included 54 breast cancer tumors and adjacent normal tissues.
- Expression levels were analyzed before neoadjuvant chemotherapy.
Main Results:
- Both MDR1 and MRP1 expression levels were significantly higher in breast tumors than in adjacent normal tissues.
- A significant correlation was observed between MRP1 expression and response to chemotherapy.
- No significant association was found between MDR1 expression and response to treatment.
- MDR1 and MRP1 expression were independent of tumor size, histological grade, and hormone receptor status.
Conclusions:
- MRP1, but not MDR1, expression is associated with chemotherapy response in breast cancer patients.
- Elevated MDR1 and MRP1 expression in tumors suggests their involvement in breast cancer drug resistance.
- MRP1 may serve as a potential biomarker for predicting treatment efficacy in breast cancer.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
09:33Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Abnormal Proliferation
Clinical Significance of Antibiotic Resistance
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...